RSV Bronchiolitis – PediaCast CME 021
Podcast: Download
Subscribe: RSS
Show Notes / Continuing Medical Education Information
DESCRIPTION
Join us for an up-to-date briefing on RSV bronchiolitis. We cover the organism, the disease, evidence-based treatment guidelines, Synagis prophylaxis and the development of an RSV vaccine. My guests include Drs Asuncion Mejias, Christopher Timan and Karen McCoy.
CME CREDIT FOR THIS ACTIVITY HAS EXPIRED
TOPICS
RSV Bronchiolitis
Synagis Prophylaxis
RSV Vaccine
PRESENTERS
Dr Mike Patrick
PediaCast and PediaCast CME
Nationwide Children’s Hospital
Dr Asuncion Mejias
Pediatric Infectious Disease
Principal Investigator, Vaccines
Nationwide Children’s Hospital
Dr Christopher Timan
Neonatology & Synagis Expert
Nationwide Children’s Hospital
Dr Karen McCoy
Chief of Pediatric Pulmonology
Nationwide Children’s Hospital
LINKS
Synagis Program at Nationwide Children’s
Synagis Center Home
Synagis Center Parent Information
Synagis Access 360 – Access and Affordability Program
Synagis Access 360 Telephone: 1-844-275-2360
PediaByte 0536: RSV Bronchiolitis & Synagis
Respiratory Syncytial Virus (RSV)
Bronchiolitis in Babies
Bronchiolitis vs Colds
Treating Infant Bronchiolitis
Protecting Your Baby from RSV
PURPOSE
This online activity will identify and explore issues related to the practice of pediatric medicine in primary care and subspecialty settings.
TARGET AUDIENCE
Primary care physicians, pediatric subspecialists, and other health care professionals who provide care for pediatric patients should participate in this activity.
EDUCATIONAL OBJECTIVES
At the end of this activity, participants should be able to:
- Summarize the chief elements of RSV bronchiolitis: causative organism, epidemiology, pathophysiology, signs/symptoms, differential diagnosis and work-up.
- Develop an evidence-based treatment plan for the patient presenting with RSV bronchiolitis.
- Identify infants who qualify for Synagis prophylaxis, find a local supply of the injection and plan an administration schedule.
- Assess the state of RSV vaccine development, including progress and barriers.
DISCLOSURES
No one in a position to control content has any relationships with commercial interests.
COMMERCIAL SUPPORT
Nationwide Children’s has not received any commercial support for this activity.
ESTIMATED TIME TO COMPLETE
1 Hour
DATE OF ORIGINAL RELEASE
November 16, 2016
EXPIRATION DATE
November 16, 2019
CME CREDIT AND PROVIDER INFORMATION
Nationwide Children’s Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nationwide Children’s Hospital designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ACCME requires CME providers to maintain records of attendance for 6 years after participation.
Currently, there is no fee to obtain Category 1 CME Credit from this activity.
Please contact the Nationwide Children’s CME Office with any questions:
Email: CMEOffice@nationwidechildrens.org
Nationwide Children’s Hospital
Education Department, CME Office
700 Children’s Drive
Columbus, OH 43205
614-355-0650
